Incyte Corporation ( INCY) - Stock Earnings
INCY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026, midnight | — / — | — | — / — | — |
INCY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 299.3 million USD | 1.5 billion USD |
| 2026Q1 | 303.3 million USD | 1.3 billion USD |
| 2026Q2 | 585.6 million USD | 1.7 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INCY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 597.6 million USD | 3.7 billion USD |
| 2024 | 32.6 million USD | 4.2 billion USD |
| 2025 | 1.3 billion USD | 5.1 billion USD |
| 2026 Est. | — | — |
INCY
Price: $116.59
Earnings Per Share: 7.85 USD
P/E Ratio: 15.23
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -135.0 millionMarket Capitalization: 22.9 billion